Celcuity, Inc. (CELC)
99.33
-0.59
(-0.59%)
USD |
NASDAQ |
Dec 31, 11:21
Celcuity Shareholders Equity (Quarterly): 116.96M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Olema Pharmaceuticals, Inc. | 307.49M |
| Replimune Group, Inc. | 263.34M |
| Arrowhead Pharmaceuticals, Inc. | 466.05M |
| Cidara Therapeutics, Inc. | 422.39M |
| Cogent Biosciences, Inc. | 302.46M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 476.00M |
| Total Liabilities (Quarterly) | 359.04M |
| Debt to Equity Ratio | 2.739 |
| Current Ratio | 12.26 |
| Net Debt Paydown Yield | -2.09% |